Key Highlights
- JOGO Health raised over $5.5 million in investment round led by Hourglass Ventures.
- Opening round to public retail investors via Wefunder.
- FDA-cleared, Medicare-reimbursed, non-invasive treatment for chronic pain and neuromuscular disorders.
- Supported by 18 patents and over 25,000 patients treated.
Source: Business Wire
Notable Quotes
- “The conviction of our investors is phenomenal. This round will enable us to meet growing demand.” — Siva Nadarajah, President and Co-Founder at JOGO Health
- “We believe healthcare is too important to be controlled by a few. JOGO is founded on the vision of ‘by the world, for the world,’ and opening our investment round to retail investors on Wefunder is a crucial step towards realizing this vision.” — Sanjai Murali, CEO and Co-Founder at JOGO Health
SoHC's Take
JOGO Health’s decision to open its investment round to the public via Wefunder is a significant step in democratizing access to healthcare innovation. The company’s non-invasive, drug-free treatments are positioned to make a profound impact on the $380 billion neuromuscular disorder market. Backed by reputable institutions like Mayo Clinic Ventures and armed with robust FDA clearances, JOGO’s expansion could redefine chronic pain management and neuromuscular recovery. The leadership’s proven track record in healthcare innovation further enhances JOGO’s credibility and potential for success. This inclusive approach not only fosters broader investment opportunities but also aligns with JOGO’s vision of making healthcare advancements accessible to all.
